31 devices · GMDN 47351
B-type natriuretic protein (BNP) and N-terminal proBNP (NT-proBNP) immunoassay kits use chemiluminescence to measure heart failure biomarkers in blood or serum. Clinically, these tests help diagnose and monitor conditions like congestive heart failure by quantifying peptide levels linked to cardiac stress.
These devices are typically regulated as in vitro diagnostics (IVDs) and may require compliance with standards like ISO 13485 or FDA 510(k) clearance. They are supplied as reagent kits for laboratory use, often requiring specialized instrumentation for accurate chemiluminescent detection.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.